Glenmark Pharma gets USFDA gesture for nervous system stimulant drug Kumar Jeetendra | January 29, 2021 Drug major Glenmark Pharma on Thursday said it has received final acceptance from the US health regulator for central nervous system stimulant medication Amphetamine Sulfate tablets. The approved product is a generic version of Evekeo tablets of Arbor Pharmaceuticals LLC. Quoting IQVIA sales statistics for the 12 month period ending November 2020, Glenmark said Evekeo …
Cipla champions its commitment to carbon neutrality with its 30 MW solar plant in Maharashtra Kumar Jeetendra | January 27, 2021 India; January 27, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced that it has set up a 30 MW solar group captive project in Tuljapur, Maharashtra. Spread across 115 acres, the solar project has been commissioned in partnership with AMP Energy India, and is one of the largest solar …
Albumedix submits Drug Master Files for its products in Japan Kumar Jeetendra | January 25, 2021 Nottingham, UK – January 25th, 2021 – Life Science Newswire – Albumedix Ltd. (‘Albumedix’), the world leader in recombinant human albumin (rHA), announced the submission of Drug Master Files (DMFs) to the Pharmaceutical and Medical Device Agency (PMDA) in Japan. Albumedix has submitted DMFs for two of their products in order to further support customers …
Strides Pharma gets USFDA gesture for conventional medication Kumar Jeetendra | January 25, 2021 New Delhi, Jan 25 (PTI) Strides Pharma Science on Monday said it has received approval from the US health regulator to market generic Ursodiol capsules, used in the treatment of Primary Biliary Cirrhosis (PBC), in the American market. The company”s product is bioequivalent and therapeutically equivalent to Allergan Sales” Actigall capsules, it added. Based on …
Japan to begin Covid immunizations with Pfizer vaccine Kumar Jeetendra | January 22, 2021 Japan’s vaccine programme chief Taro Kono said on Friday the country would begin coronavirus vaccinations with Pfizer’s vaccine, and aimed to start vaccinations as early as late February with 10,000 medical workers at 100 hospitals. Kono told reporters the next priority after medical workers was to vaccinate the elderly, those with health conditions and elderly …
Strides Pharma Science arm gets USFDA gesture for HIV treatment drug Kumar Jeetendra | January 15, 2021 Drug firm Strides Pharma Science on Friday said its step-down wholly-owned subsidiary, Strides Pharma Global, has obtained approval from the US health regulator for Emtricitabine and Tenofovir Disoproxil Fumarate pills, used to treat HIV. The approved product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Truvada tablets of Gilead Sciences. Strides Pharma …
Jellagen dispatches JellaGel™, the principal Collagen Type 0 Hydrogel taking available driving Extracellular Matrix Kumar Jeetendra | January 15, 2021 Jellagen® Limited, a biotechnology company manufacturing high-value Collagen Type 0 derived from jellyfish, announce the launch of their JellaGel™ Hydrogel. 3-dimensaional Hydrogels make it possible for cells to grow and interact with all of their surroundings that makes a massive difference. Cells grown in a 3D model have been shown to be more natural, with …
India needs Pfizer to do nearby examination for approval: Official Kumar Jeetendra | January 13, 2021 Any vaccine manufacturer, such as Pfizer Inc, which has sought emergency-use authorisation for its COVID-19 shot in India, must run a neighborhood”bridging” safety and immunogenicity study to be considered for the country’s immunisation programme, a senior government official told Reuters. Serum Institute of India, the local maker of the vaccine developed by AstraZeneca Plc and …
Granules India gets USFDA endorsement for Metformin Hydrochloride ER tablets Kumar Jeetendra | January 13, 2021 Granules India Limited today announced that United States Food & Drug Administration (USFDA) has given the final approval for its abbreviated new drug application (ANDA) for Metformin Hydrochloride extended-release tablets USP, 500 mg and 1,000 mg. These tablets are the generic equivalent of Glumetza ER tablets, 500 mg & 1,000 milligrams of Bausch Health US …
Cipla to Present at the 39th Annual J.P. Morgan Healthcare Conference Kumar Jeetendra | January 12, 2021 India; January 12, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced that it will participate at the 39th Annual J.P. Morgan Healthcare Conference, which is the largest healthcare investment symposium in the industry. Mr. Umang Vohra, MD and Global CEO, Cipla, will virtually present a corporate overview of the …
Dr Reddy’s’ dispatches generic medication in the US market Kumar Jeetendra | January 11, 2021 New Delhi, Jan 11 (PTI) Dr Reddy”s Laboratories on Monday said it has launched Febuxostat tablets, used to treat gout due to high uric acid levels, in the US market. The company has launched the product, which is a generic version of Teijin Ltd”s Uloric tablets, after getting approval from the US Food and Drug …
Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in US Kumar Jeetendra | January 10, 2021 New Delhi, Jan 10 (PTI) Drug major Cipla is recalling more than 5.8 lakh packets of a drug for the reduction in the occurrence of gastric ulcers from the US market, as per a report from the US Food and Drug Administration. The medication major is recalling esomeprazole magnesium for delayed-release oral suspension in unit …
